Hayashi, Y. et al. 2025. Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis. Journal of Hematology. 14, 2 (Apr. 2025), 66–73. DOI:https://doi.org/10.14740/jh2010.